Bizarre Patents
Crispy Chip Sandwich and Process of Producing a Sandwich Product
A food product comprising a multilayer cookie or snack having outer layers formed from a crispy type edible food product such as a potato chip or corn chip, etc. with an intermediate marshmallow layer being in contact with the inner surface of each crispy chip and one or more filler substances.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120129860 | STYRENYL DERIVATIVE COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative... | 05/24/2012 |
| 20120046272 | Novel Therapeutic Compounds The present invention describes a series of therapeutically active compounds of formula I,
that are useful for treating a disorder in a mammal. In the f... | 02/23/2012 |
| 20120040019 | Medicated ointment for treating hemorrhoid and method of using the same This invention relates to an externally applied ointment that aids in relieving irritation, pain or mild inflammation of the skin or mucous membranes associated with hemorrhoids and the method of using such ointment lotion. The formulation of the present invention conta... | 02/16/2012 |
| 20120034307 | Aqueous gel formulation and method for inducing topical anesthesia Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is... | 02/09/2012 |
| 20120029085 | STABILIZATION OF QUINOL COMPOSITION SUCH AS CATECHOLAMINE DRUGS Compositions and methods are provided for obtaining stabilized quinol compositions, such as catecholamine drugs (e.g., epinephrine solutions), and also for obtaining stable pharmaceutical formulations that comprise a stabilized quinol composition and a second pharmacolo... | 02/02/2012 |
| 20120029086 | Compositions and Method for Temporary Reduction of Nasal and Sinus Pain Compositions and method that are expedient, safe, non-habit forming, and non-sedating for temporary reduction of nasal and sinus pain comprised of a local anesthetic or local anesthetics in a pharmaceutically acceptable carrier by instillation into the nasal cavity and ... | 02/02/2012 |
| 20120024743 | TRANSDERMAL PHARMACEUTICAL PREPARATIONS The present invention relates to semisolid transdermal pharmaceutical preparation having enhanced stability and bioavailability, wherein the particles are coated by a volatile silicon oil component and the thus obtained suspension is dispersed in a gel or cream base.... | 02/02/2012 |
| 20120028906 | METHOD FOR AFFECTING THE TIMING OF CERVICAL RIPENING AND FOR PARTURITION A method for affecting the timing of cervical ripening and the resultant onset of parturition in a pregnant female mammal, the method comprises administering to a pregnant female one or more than one dose of an agent that chemically mimics innervation of the cervix by t... | 02/02/2012 |
| 20120021989 | GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION AND STROKE The invention relates to procedures and methods of determining a susceptibility to cardiac arrhythmia, including Atrial Fibrillation, Atrial Flutter and Stroke, by assessing the presence or absence of alleles at polymorphic markers found to be associated with risk of th... | 01/26/2012 |
| 20120015901 | METHODS AND PREPARATIONS FOR PROTECTING CRITICALLY ILL PATIENTS The present invention relates to a method of treating a life threatening condition in a critically ill human patient with a non-infectuous disorder, wherein the critically ill patient is a patient receiving enteral or parenteral nutrition, the method comprising the step... | 01/19/2012 |
| 20110319790 | PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition coefficient. The active ingredient may be, for example, bupivacaine, sodium lauryl su... | 12/29/2011 |
| 20110311629 | NON-ADHESIVE ELASTIC GELATIN MATRICES The present invention is a substantially non-adhesive elastic gelatin matrix. The matrix is both non-adhesive to wounds, tissues and organs and is also elastic such that it is flexible. The matrix is a lyophilized mixture of protein(s), polymer(s), cross-linking agent(s... | 12/22/2011 |
| 20110306600 | NOVEL THERAPEUTIC COMPOUNDS The invention discloses a number of therapeutic compounds and a method of treating a disorder in mammal.... | 12/15/2011 |
| 20110301099 | Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules A method and composition that allows for the penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeable molecules as carrier molecules. S-Allyl-containing compounds can include alliin, allicin, ... | 12/08/2011 |
| 20110301131 | Drug Delivery Implants and Processes for Their Preparation The invention discloses an implant suitable for delivery of at least one drug, the implant comprising a fibrillar collagen matrix having, as measured in Example 1, a viscosity of greater than 100 mPas, optionally greater than 103 mPas, further optionally greater than 10... | 12/08/2011 |
| 20110294767 | BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS Provided herein are methods of utilizing bile acid transport inhibitors and/or enteroendocrine peptide enhancing agents for the treatment of obesity, diabetes, and inflammatory gastrointestinal conditions.... | 12/01/2011 |
| 20110294894 | Pharmaceutical Composition for the Treatment of Solar Urticaria The present invention refers to a local anesthetic, preferably selected from the group of aminoamide local anesthetics, in particular lidocaine or prilocaine, for use in the treatment or prevention of physical urticaria, in particular solar urticaria. The present invent... | 12/01/2011 |
| 20110288096 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ERYTHEMA Methods and products for treating or preventing erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical aqueous gel composition comprising about 0.01% to about 10% by weight of ... | 11/24/2011 |
| 20110288123 | FORMULATIONS FOR THE TREATMENT OF ACUTE HERPES ZOSTER PAIN The present invention provides compositions and methods that are useful for treatment of pain associated with acute herpes zoster. The aqueous compositions are non-stinging and non-irritating.... | 11/24/2011 |
| 20110281946 | POLYMERIC -BASED COMPOSITION The present invention concerns polymeric-based compositions that are useful in the delivery and sustained release of hydrophobic therapeutic and/or cosmetic agents substantially at the point of injury, infection or, in the case of purely cosmetic applications, the point... | 11/17/2011 |
| 20110268677 | Silicone Paste Compositions Silicone paste compositions are disclosed by combining a silicone organic elastomer gel with water or a hydrophilic solvent. The silicone paste compositions may further contain a personal or healthcare active. The silicone organic elastomer gel is prepared by reacting i... | 11/03/2011 |
| 20110269704 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY A liquid pharmaceutical composition to be applied to the skin as a foam and that has at least one solvent, at least one active pharmaceutical ingredient, and at least one foaming agent. The foam volume and the foam stability are determined according to a standardized SI... | 11/03/2011 |
| 20110263715 | Local Anesthetic Emulsion Compositions and Methods of Making and Using the Same Local anesthetic emulsion compositions are provided. The local anesthetic emulsion compositions may include: an oily phase comprising a eutectic mixture of a local anesthetic and an acyclic amide; a surfactant; and an aqueous phase. Also provided are methods of making a... | 10/27/2011 |
| 20110251197 | LYSOSOMOTROPIC INHIBITORS OF ACID CERAMIDASE The presently disclosed subject matter provides compounds of the formula, formula (Ia): and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, R5, X, Y, and n are as defined herein. Also disclosed ar... | 10/13/2011 |
| 20110244043 | Controlled releasing composition A controlled releasing composition comprising a plurality of microparticles and a matrix as well as the preparation method thereof is disclosed. The plurality of microparticles comprise a first material and the matrix comprises a second material. The melting temperature... | 10/06/2011 |
| 20110237611 | CHEMICAL PERMEATION ENHANCERS ENHANCE NERVE BLOCKADE BY TOXINS Chemical permeation enhancers (CPEs) improve access of local anesthetics to the nerve, thereby improving their performance. Surfactants, representing three CPE sub-groups: anionic, cationic, and nonionic surfactants, were co-injected with tetrodotoxin (TTX) or bupivacai... | 09/29/2011 |
| 20110230534 | Composition For Local Anesthesia An object of the present invention is to provide a composition for local anesthesia to be added to a local anesthetic drug, the composition showing a sustained local anesthetic effect and having high safety. The object is achieved by a composition for local anesthesia i... | 09/22/2011 |
| 20110224305 | PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF Phenylcyclobutylamide derivatives and their optical isomers, the preparing processes and the uses thereof, which includes the compounds of formula (I), their pure stereoisomers and their pharmaceutically acceptable salts. In formula (I), R is H, formacyl, acetyl, haloac... | 09/15/2011 |
| 20110212166 | CARNITINE CONJUGATES OF ADAMANTANAMINES DERIVATIVES AS DUAL PRODRUGS FOR VARIOUS USES This invention concerns compounds of adamantanamines and neramexane, including their pharmaceutically-acceptable salts, diesterioisomers, and formulations for treating Alzheimer's related dementias, depression, AIDS related dementias, as antivirals, inflammatory disease... | 09/01/2011 |
| 20110201571 | HEAT STERILISED INJECTABLE COMPOSITION OF HYALURONIC ACID OR ONE OF THE SALTS THEREOF, POLYOLS AND LIDOCAINE An injectable aqueous composition of hyaluronic acid or one of the salts thereof, one or more polyol(s) and lidocaine is used for cosmetic purposes or for therapeutic purposes. It has improved viscoelastic rheological properties and long in vivo persistence. The polyol ... | 08/18/2011 |
| 20110196014 | METHIONINE ANALOGS AND METHODS OF USING SAME Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfec... | 08/11/2011 |
| 20110189292 | DERMAL FILLERS COMPRISING SILK FIBROIN HYDROGELS AND USES THEREOF The present specification provides compositions useful as dermal fillers and methods using such compositions to treat a condition of skin.... | 08/04/2011 |
| 20110182849 | COMPOSITIONS AND METHODS FOR TREATING AN INTERVERTEBRAL DISC USING BULKING AGENTS OR SEALING AGENTS Effective compositions and methods for treating an intervertebral disc are provided. The compositions and methods comprise a bulking agent or sealing agent, the bulking agent or sealing agent adapted to be administered at or within the intervertebral disc, the bulking o... | 07/28/2011 |
| 20110182952 | DRUG DELIVERY FROM EMBOLIC AGENTS A pharmaceutical composition for embolization of blood vessels, especially for benign tumours, comprises a polymeric embolic agent and, associated with the polymer in a releasable form, a local anaesthetic agent. The polymer is preferably in particulate form, such as in... | 07/28/2011 |
| 20110184068 | USE OF (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDES FOR THE MANUFACTURE OF MEDICAMENTS ACTIVE AS SODIUM AND/OR CALCIUM CHANNEL SELECTIVE MODULATORS The invention relates to the use of selected (R)-2-[(halobenzyloxy)benzylamino]-propanamides and the pharmaceutically acceptable salts thereof for the manufacture of medicament, that are selectively active as sodium and/or calcium channel modulators and therefore useful... | 07/28/2011 |
| 20110171325 | Systems and Methods for Treating Pain Using Brain Stimulation The invention comprises systems and methods for treating nociceptive pain including at least one force-regulatable device in mechanical, electrical, or chemical communication with at least one brain area identified as processing nociceptive pain signals. The force-regul... | 07/14/2011 |
| 20110171311 | STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions.... | 07/14/2011 |
| 20110166060 | TYMPANIC MEMBRANE PERMEATING EAR DROPS AND USES THEREOF The present invention provides compositions and methods for noninvasive delivery of therapeutic agents across an intact tympanic membrane. For example, the compositions include a penetration enhancer which increases the flux of a therapeutic agent (e.g., antibiotic) acr... | 07/07/2011 |
| 20110159304 | ANTI-SULPHATE REDUCING BACTERIA COMPOSITION COMPRISING 1,2-BENZISOTHIAZOL-3(2H)-ONE, IRGASAN, BENZYL-2-BROMOACETATE, 2,2-DIBROMO-2-CYANOACETAMIDE, AND 2-BROMO-2-NITROPROPAN-1,3-DIOL Disclosed are a composition for inhibiting a proliferation of sulphate reducing bacteria comprising at least one of 1,2-benzisothiazol-3(2H)-one, irgasan, benzyl-2-bromoacetate, 2,2-dibromo-2-cyanoacetamide, and 2-bromo-2-nitropropan-1,3-diol as effective ingredients; a... | 06/30/2011 |
| 20110152377 | EXTERNAL PREPARATION COMPRISING FATTY ACID SALT OR BENZOIC ACID SALT OF BASIC PHARMACOLOGICALLY ACTIVE COMPONENT, AND METHOD FOR PRODUCTION THEREOF It has been demanded to develop a formulation for a novel external preparation having excellent transdermal absorption of a basic pharmacologically active component contained therein. It is found that the lipid solubility (logP values) of a basic pharmacologically activ... | 06/23/2011 |
